Nautilus Biotechnolgy's total assets for Q3 2025 were $200.91M, a decrease of -5.76% from the previous quarter. NAUT total liabilities were $31.78M for the fiscal quarter, a -0.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.